Takeda

News

Takeda, Daiichi-backed wearable study planned in Japan

A study that will look at the feasibility of tracking people's lifestyle habits for an extended period using a wearable device has got underway in Japan, backed by drugmakers Takeda and Dai

Market Access

Deep Dive: Market Access

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge.

News

Takeda spinout Phathom claims its first FDA approvals

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financin

News

NHS grants fast-track access to Takeda's lung cancer drug Ex...

Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few weeks.

News

Science Molecule, Molecular DNA Model Structure, business teamwork conceptMolecular, DNA and atom model in science research labMolecular, DNA and atom model in science research lab setting in studio.

Takeda grows in gene therapies again with $2bn Code Bio deal

Takeda has forged another alliance as it continues a push into gene therapy, agreeing a deal worth up to $2 billion with Code Biotherapeutics for opt-in rights to four candidates for rare d

News

FDA knocks back Takeda's blockbuster hope TAK-721

Japanese drugmaker Takeda has suffered a blow to its late-stage pipeline, after the FDA rejected its marketing application for TAK-721, a drug candidate that is trying to be the first appro

Takeda, Daiichi-backed wearable study planned in Japan

Deep Dive: Market Access

Takeda spinout Phathom claims its first FDA approvals

NHS grants fast-track access to Takeda's lung cancer drug Ex...

Takeda grows in gene therapies again with $2bn Code Bio deal

FDA knocks back Takeda's blockbuster hope TAK-721

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Takeda

Editor's Picks